In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts.
In this three part series, Dr. Bays and Dr. Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors.
Tiffany Lowe-Clayton, DO Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Episode Description In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM interviews Angela Fitch, MD, FACP, FOMA, to discuss a...
Episode Description In this episode, the OMA Chief Science Officer, Dr. Harold Bays, FOMA Dipl. ABOM interviews Nicholas Pennings, DO, FOMA, Dipl. ABOM about...
Episode Description In this episode, the OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM interviews Krishna Doniparthi, MD, FAARM, FOMA, reviewing a...